Icon

BYFAVO (nda212295)- (EQ 20MG BASE/VIAL)

REMIMAZOLAM BESYLATE ACACIA
EQ 20MG BASE/VIAL
Yes Yes
2034-Jan-13 2025-Oct-06
None None
None No
BYFAVO(remimazolam) for injection is a benzodiazepine indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 20MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.